ATE297727T1 - Verwendung von anethol-dithiolethion zur vorbeugung und behandlung der sehnentoxizität - Google Patents
Verwendung von anethol-dithiolethion zur vorbeugung und behandlung der sehnentoxizitätInfo
- Publication number
- ATE297727T1 ATE297727T1 AT01929703T AT01929703T ATE297727T1 AT E297727 T1 ATE297727 T1 AT E297727T1 AT 01929703 T AT01929703 T AT 01929703T AT 01929703 T AT01929703 T AT 01929703T AT E297727 T1 ATE297727 T1 AT E297727T1
- Authority
- AT
- Austria
- Prior art keywords
- dithiolethone
- anethol
- prevent
- toxicity
- treat tendon
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Lubricants (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0005247A FR2807944B1 (fr) | 2000-04-25 | 2000-04-25 | Utilisation de l'anethole-dithiolethione dans la prevention et le traitement de la tenotoxicite induite par un medicament |
| PCT/FR2001/001268 WO2001080856A2 (fr) | 2000-04-25 | 2001-04-25 | Utilisation de l'anethole-dithiolethione dans la prevention et le traitement de la tenoxicite induite par un medicament |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE297727T1 true ATE297727T1 (de) | 2005-07-15 |
Family
ID=8849561
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01929703T ATE297727T1 (de) | 2000-04-25 | 2001-04-25 | Verwendung von anethol-dithiolethion zur vorbeugung und behandlung der sehnentoxizität |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20030187067A1 (de) |
| EP (1) | EP1351680B8 (de) |
| JP (1) | JP2003531172A (de) |
| AT (1) | ATE297727T1 (de) |
| AU (1) | AU2001256406A1 (de) |
| CA (1) | CA2406998A1 (de) |
| DE (1) | DE60111571T2 (de) |
| ES (1) | ES2245361T3 (de) |
| FR (1) | FR2807944B1 (de) |
| HU (1) | HUP0301810A2 (de) |
| PT (1) | PT1351680E (de) |
| WO (1) | WO2001080856A2 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103113360B (zh) * | 2013-02-19 | 2015-01-28 | 东南大学 | 一种阿托伐他汀衍生物、其药物组合物及制药应用 |
| US11554106B2 (en) * | 2017-03-07 | 2023-01-17 | Marc Childs | Prevention of the risks associated with drug-induced QT interval prolongation by using a specific inhibitor of the production of ROS of miochondrial origin |
| WO2018162846A1 (fr) * | 2017-03-07 | 2018-09-13 | Sauzieres, Jacques | Prévention des effets adverses des especes reactives de l'oxygene d'origine mitochondriale à l'aide d'un inhibiteur specifique de la production de ros d'origine mitochondriale |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP9601808A3 (en) * | 1995-07-03 | 2000-06-28 | Sankyo Co | Treatment of arteriosclerosis and xanthoma |
-
2000
- 2000-04-25 FR FR0005247A patent/FR2807944B1/fr not_active Expired - Lifetime
-
2001
- 2001-04-25 AT AT01929703T patent/ATE297727T1/de not_active IP Right Cessation
- 2001-04-25 ES ES01929703T patent/ES2245361T3/es not_active Expired - Lifetime
- 2001-04-25 WO PCT/FR2001/001268 patent/WO2001080856A2/fr active IP Right Grant
- 2001-04-25 PT PT01929703T patent/PT1351680E/pt unknown
- 2001-04-25 US US10/258,520 patent/US20030187067A1/en not_active Abandoned
- 2001-04-25 AU AU2001256406A patent/AU2001256406A1/en not_active Abandoned
- 2001-04-25 JP JP2001577955A patent/JP2003531172A/ja not_active Withdrawn
- 2001-04-25 HU HU0301810A patent/HUP0301810A2/hu unknown
- 2001-04-25 DE DE60111571T patent/DE60111571T2/de not_active Expired - Fee Related
- 2001-04-25 EP EP01929703A patent/EP1351680B8/de not_active Expired - Lifetime
- 2001-04-25 CA CA002406998A patent/CA2406998A1/fr not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| FR2807944B1 (fr) | 2003-06-13 |
| ES2245361T3 (es) | 2006-01-01 |
| EP1351680B8 (de) | 2005-08-17 |
| EP1351680A2 (de) | 2003-10-15 |
| HUP0301810A2 (hu) | 2003-09-29 |
| CA2406998A1 (fr) | 2001-11-01 |
| PT1351680E (pt) | 2005-10-31 |
| DE60111571T2 (de) | 2006-05-11 |
| JP2003531172A (ja) | 2003-10-21 |
| DE60111571D1 (de) | 2005-07-21 |
| WO2001080856A2 (fr) | 2001-11-01 |
| WO2001080856A3 (fr) | 2003-04-24 |
| US20030187067A1 (en) | 2003-10-02 |
| FR2807944A1 (fr) | 2001-10-26 |
| AU2001256406A1 (en) | 2001-11-07 |
| EP1351680B1 (de) | 2005-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602004017736D1 (de) | Verwendung von rapamycin und dessen derivaten zur behandlung von knochenverlust | |
| DE60031396D1 (de) | Zubereitung zur behandlung von einer neurologischen erkrankung | |
| DE60124302D1 (de) | Thiazolderivate zur behandlung von ppar-lierte krankheiten | |
| DE60124684D1 (de) | Sulfonamido-substituierte verbrückte bicycloalkylderivative | |
| ATE346614T1 (de) | Vaginale zusammensetzung enthaltend lidocaine zur behandlung von gebärmutterrhythmusstörung | |
| ATE357438T1 (de) | 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems | |
| DE69825286D1 (de) | Verwendung von cholinesterasehemmern zur behandlung von aufmerksamkeitsmangel-störungen | |
| DE69825440D1 (de) | VERWENDUNG VON TAUROLIDINE ZUR Herstellung eines Arzneimittels zur BEHANDLUNG VON LEUKÄMIEN | |
| NO20025405D0 (no) | Modulatorer for TNF-alfa-signalisering | |
| DE69918972D1 (de) | Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen | |
| DE50114605D1 (de) | No-thien-2-yl-essigsaure-derivate und ihre verwendung zur behandlung von migraine bzw. schmerz | |
| DE50105735D1 (de) | Chlorzoxazon zur behandlung von psoriasis | |
| ATE217191T1 (de) | Verwendung von phanquinon zur behandlung von alzheimer's krankheit | |
| DE69931487D1 (de) | Verwendung von apomorphin zur behandlung der vorzeitigen ejakulation | |
| ATE402694T1 (de) | Verwendung von 1-phenyl-3-dimethylamino-propan- verbindungen zur therapie der harninkontinenz | |
| ATE297727T1 (de) | Verwendung von anethol-dithiolethion zur vorbeugung und behandlung der sehnentoxizität | |
| ATE361071T1 (de) | Verwendung von irbesartan zur vorbeugung oder behandlung pulmonaler hypertonie | |
| ATE354361T1 (de) | Neue verwendung von prodigiosin zur behandlung von diabetes mellitus | |
| DE69936779D1 (de) | Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen | |
| DE60124093D1 (de) | S-methyl-dihydro-ziprasidon zur Behandlung von Augenerkrankungen. | |
| DE69926996D1 (de) | Verwendung von riluzol zur behandlung der retinalischemie | |
| ATE275949T1 (de) | Verwendung von diminazen-di-aceturat und/oder pentamidin zur behandlung von malaria | |
| DE59904564D1 (de) | Verwendung von acetylcholinesterase-inhibitoren zur behandlung von delirien | |
| ATE303158T1 (de) | Verwendung von beta-interferon zur behandlung der restenose | |
| DE60326348D1 (de) | Makrozyclen zur behandlung von krebserkrankungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |